Stocks Overview

LAST PRICE
55.5400
TODAY'S CHANGE (%)
Trending Down-0.7100 (-1.2622%)

Bid / Lots
54.4700/ 1
Ask / Lots
58.1500/ 2
Open / Previous Close
55.8700 / 56.2500
Day Range
Low 54.9400
High 55.8700
52 Week Range
Low 42.6300
High 58.9700
Volume
1,761,011
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 56.25
Time	Volume	SNY
09:32 ET	5864	55.82
09:34 ET	3984	55.73
09:36 ET	4861	55.72
09:38 ET	1145	55.63
09:39 ET	7460	55.59
09:41 ET	4915	55.54
09:43 ET	3575	55.53
09:45 ET	4195	55.47
09:48 ET	11110	55.535
09:50 ET	4396	55.515
09:52 ET	28031	55.52
09:54 ET	3068	55.52
09:56 ET	54263	55.395
09:57 ET	15872	55.36
09:59 ET	4101	55.47
10:01 ET	4872	55.375
10:03 ET	12122	55.4647
10:06 ET	5750	55.45
10:08 ET	9834	55.51
10:10 ET	6195	55.53
10:12 ET	5395	55.56
10:14 ET	2300	55.52
10:15 ET	7128	55.465
10:17 ET	5887	55.415
10:19 ET	62167	55.47
10:21 ET	37259	55.49
10:24 ET	8849	55.44
10:26 ET	6279	55.42
10:28 ET	1800	55.415
10:30 ET	3873	55.38
10:32 ET	1600	55.29
10:33 ET	60970	55.3
10:35 ET	4351	55.3381
10:37 ET	13940	55.28
10:39 ET	37912	55.27
10:42 ET	23224	55.2033
10:44 ET	22923	55.175
10:46 ET	4172	55.26
10:48 ET	67891	55.3
10:50 ET	6173	55.28
10:51 ET	3126	55.23
10:53 ET	21479	55.23
10:55 ET	16761	55.22
10:57 ET	10732	55.25
11:00 ET	7133	55.175
11:02 ET	18067	55.08
11:04 ET	10197	55.11
11:06 ET	13141	55.07
11:08 ET	11947	55.15
11:09 ET	5907	55.12
11:11 ET	8358	55.06
11:13 ET	11285	55.01
11:15 ET	9842	55.02
11:18 ET	4071	54.96
11:20 ET	3400	54.99
11:22 ET	30521	55
11:24 ET	13262	55.025
11:26 ET	5717	55.03
11:27 ET	2206	55.03
11:29 ET	1751	55.035
11:31 ET	6343	55.03
11:33 ET	2150	55.06
11:36 ET	10161	55.11
11:38 ET	2029	55.13
11:40 ET	1524	55.135
11:42 ET	5019	55.22
11:44 ET	1266	55.245
11:45 ET	3694	55.365
11:47 ET	508	55.39
11:49 ET	3708	55.34
11:51 ET	2391	55.34
11:54 ET	600	55.35
11:56 ET	1518	55.34
11:58 ET	3406	55.27
12:00 ET	2768	55.28
12:02 ET	2231	55.25
12:03 ET	2526	55.28
12:05 ET	600	55.27
12:07 ET	3024	55.29
12:09 ET	719	55.3
12:12 ET	621	55.3
12:14 ET	1517	55.32
12:16 ET	907	55.34
12:18 ET	1975	55.33
12:20 ET	1871	55.3
12:21 ET	2738	55.315
12:23 ET	1206	55.35
12:25 ET	978	55.36
12:27 ET	3206	55.36
12:30 ET	1110	55.36
12:32 ET	2448	55.35
12:34 ET	500	55.35
12:36 ET	1402	55.32
12:38 ET	1147	55.3261
12:39 ET	4257	55.38
12:41 ET	3252	55.36
12:43 ET	1580	55.33
12:45 ET	1050	55.31
12:48 ET	1064	55.32
12:50 ET	3092	55.31
12:52 ET	2398	55.29
12:54 ET	2483	55.27
12:56 ET	3167	55.28
12:57 ET	615	55.32
12:59 ET	1767	55.3078
01:01 ET	900	55.31
01:03 ET	2059	55.32
01:06 ET	1398	55.305
01:08 ET	2252	55.33
01:10 ET	1400	55.35
01:12 ET	1101	55.35
01:14 ET	674	55.36
01:15 ET	267	55.375
01:17 ET	4238	55.395
01:19 ET	300	55.39
01:21 ET	2147	55.4
01:24 ET	975	55.405
01:26 ET	2358	55.405
01:28 ET	2750	55.4
01:30 ET	500	55.3625
01:32 ET	5079	55.41
01:33 ET	678	55.415
01:35 ET	1120	55.415
01:37 ET	2379	55.425
01:39 ET	28198	55.43
01:42 ET	1077	55.41
01:44 ET	2061	55.39
01:46 ET	901	55.39
01:48 ET	3426	55.4
01:50 ET	7172	55.385
01:51 ET	500	55.39
01:53 ET	2975	55.38
01:55 ET	6248	55.4
01:57 ET	1711	55.395
02:00 ET	6116	55.4
02:02 ET	1964	55.395
02:04 ET	4194	55.4
02:06 ET	1814	55.4
02:08 ET	5912	55.395
02:09 ET	1801	55.395
02:11 ET	11316	55.49
02:13 ET	5588	55.475
02:15 ET	3620	55.47
02:18 ET	2425	55.48
02:20 ET	1185	55.48
02:22 ET	5684	55.48
02:24 ET	10469	55.51
02:26 ET	4918	55.54
02:27 ET	4578	55.54
02:29 ET	4317	55.6
02:31 ET	10688	55.605
02:33 ET	3451	55.605
02:36 ET	2202	55.605
02:38 ET	4560	55.625
02:40 ET	4849	55.62
02:42 ET	4451	55.595
02:44 ET	3362	55.59
02:45 ET	3468	55.56
02:47 ET	2100	55.56
02:49 ET	13322	55.58
02:51 ET	2455	55.545
02:54 ET	2265	55.555
02:56 ET	1300	55.555
02:58 ET	5639	55.575
03:00 ET	2345	55.575
03:02 ET	6427	55.555
03:03 ET	2263	55.555
03:05 ET	6700	55.585
03:07 ET	2306	55.58
03:09 ET	3158	55.54
03:12 ET	4154	55.545
03:14 ET	2225	55.545
03:16 ET	3313	55.545
03:18 ET	6670	55.56
03:20 ET	3497	55.565
03:21 ET	3046	55.561
03:23 ET	2915	55.555
03:25 ET	1172	55.555
03:27 ET	2659	55.555
03:30 ET	3900	55.565
03:32 ET	6914	55.575
03:34 ET	14559	55.58
03:36 ET	6341	55.595
03:38 ET	3784	55.5958
03:39 ET	6291	55.555
03:41 ET	2981	55.55
03:43 ET	10108	55.525
03:45 ET	10493	55.505
03:48 ET	7893	55.54
03:50 ET	4712	55.535
03:52 ET	16407	55.53
03:54 ET	9304	55.51
03:56 ET	21194	55.515
03:57 ET	35673	55.495
03:59 ET	124367	55.54

Data delayed at least 15 minutes.

Sep 27, 2024
- DJ Regeneron, Sanofi Get FDA OK of Dupixent for COPD -- Update, from 1:05PM ET on Friday Sep 27, 2024 by Dow Jones
  1:05PM ET on Friday Sep 27, 2024 by Dow Jones
- DJ Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD, from 9:54AM ET on Friday Sep 27, 2024 by Dow Jones
  9:54AM ET on Friday Sep 27, 2024 by Dow Jones
- Dupixent(R) (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD, from 9:35AM ET on Friday Sep 27, 2024 by Dow Jones
  9:35AM ET on Friday Sep 27, 2024 by Dow Jones
- Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD, from 9:35AM ET on Friday Sep 27, 2024 by Dow Jones
  9:35AM ET on Friday Sep 27, 2024 by Dow Jones
- Dupixent(R) (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD), from 7:00AM ET on Friday Sep 27, 2024 by Dow Jones
  7:00AM ET on Friday Sep 27, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesSNY Sanofi SA	143.5B	29.9x	+4.55%
United StatesPFE Pfizer Inc	162.1B	-61.0x	-7.10%
United StatesGSK GSK plc	82.4B	14.8x	+6.39%
United StatesBMY Bristol-Myers Squibb Co	109.0B	-16.6x	+4.90%
United StatesBAYRY Bayer AG	33.0B	-23.2x	---
United StatesMRK Merck & Co Inc	284.1B	20.4x	-43.23%
As of 2024-10-03

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Contact Information

Headquarters: 46 Avenue de la Grande ArmeePARIS, France 75017
Phone: ---
Fax: ---

Executives

Independent Chairman of the Board: Frederic Oudea
Chief Executive Officer, Executive Director, Member of the Executive Committee: Paul Hudson
Chief Financial Officer, Member of the Executive Committee: Francois-Xavier Roger
Chief People Officer, Executive Vice President, Member of the Executive Committee: Natalie Bickford
Executive Vice President, General Counsel, Member of the Executive Committee: Roy Papatheodorou

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$143.5B
Revenue (TTM)	$52.3B
Shares Outstanding	2.5B
Dividend Yield	3.67%
Annual Dividend Rate	2.0369 USD
Ex-Dividend Date	05-09-24
Pay Date	06-06-24
Beta	0.58
EPS	$1.86
Book Value	$32.68
P/E Ratio	29.9x
Price/Sales (TTM)	2.7
Price/Cash Flow (TTM)	19.9x
Operating Margin	13.92%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Sanofi SA
NASDAQ:SNYUnited States

Search Criteria

Charts

Recent News

Sep 27, 2024

DJ Regeneron, Sanofi Get FDA OK of Dupixent for COPD -- Update, from 1:05PM ET on Friday Sep 27, 2024 by Dow Jones

DJ Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD, from 9:54AM ET on Friday Sep 27, 2024 by Dow Jones

Dupixent(R) (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD, from 9:35AM ET on Friday Sep 27, 2024 by Dow Jones

Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD, from 9:35AM ET on Friday Sep 27, 2024 by Dow Jones

Dupixent(R) (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD), from 7:00AM ET on Friday Sep 27, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar